BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27482070)

  • 1. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
    Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
    Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT
    Löfdahl A; Rydell-Törmänen K; Larsson-Callerfelt AK; Wenglén C; Westergren-Thorsson G
    Sci Rep; 2018 Jan; 8(1):1927. PubMed ID: 29386571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes.
    Löfdahl A; Wenglén C; Rydell-Törmänen K; Westergren-Thorsson G; Larsson-Callerfelt AK
    Am J Pathol; 2018 May; 188(5):1113-1119. PubMed ID: 29454752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
    Kach J; Sandbo N; Sethakorn N; Williams J; Reed EB; La J; Tian X; Brain SD; Rajendran K; Krishnan R; Sperling AI; Birukov K; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L757-64. PubMed ID: 23585227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
    J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.
    Park AM; Kanai K; Itoh T; Sato T; Tsukui T; Inagaki Y; Selman M; Matsushima K; Yoshie O
    PLoS One; 2016; 11(2):e0148998. PubMed ID: 26859835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention.
    Königshoff M; Dumitrascu R; Udalov S; Amarie OV; Reiter R; Grimminger F; Seeger W; Schermuly RT; Eickelberg O
    Thorax; 2010 Nov; 65(11):949-55. PubMed ID: 20671305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.
    Fabre A; Marchal-Sommé J; Marchand-Adam S; Quesnel C; Borie R; Dehoux M; Ruffié C; Callebert J; Launay JM; Hénin D; Soler P; Crestani B
    Eur Respir J; 2008 Aug; 32(2):426-36. PubMed ID: 18321937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
    Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.
    Hutcheson JD; Ryzhova LM; Setola V; Merryman WD
    J Mol Cell Cardiol; 2012 Nov; 53(5):707-14. PubMed ID: 22940605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
    Tang N; Zhao Y; Feng R; Liu Y; Wang S; Wei W; Ding Q; An MS; Wen J; Li L
    J Cell Mol Med; 2014 Jan; 18(1):156-69. PubMed ID: 24251962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.
    Bindu S; Pillai VB; Kanwal A; Samant S; Mutlu GM; Verdin E; Dulin N; Gupta MP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L68-L78. PubMed ID: 27815257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Endothelial-to-Mesenchymal Transition Induction by Extracellular Matrix Components in Pulmonary Fibrosis.
    Grigorieva OA; Vigovskiy MA; Dyachkova UD; Basalova NA; Aleksandrushkina NA; Kulebyakina MA; Zaitsev IL; Popov VS; Efimenko AY
    Bull Exp Biol Med; 2021 Aug; 171(4):523-531. PubMed ID: 34542758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.